Cargando…
Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414762/ https://www.ncbi.nlm.nih.gov/pubmed/27427996 http://dx.doi.org/10.1097/DSS.0000000000000704 |
_version_ | 1783233415744585728 |
---|---|
author | Carruthers, Alastair Carruthers, Jean Fagien, Steven Lei, Xiaofang Kolodziejczyk, Julia Brin, Mitchell F. |
author_facet | Carruthers, Alastair Carruthers, Jean Fagien, Steven Lei, Xiaofang Kolodziejczyk, Julia Brin, Mitchell F. |
author_sort | Carruthers, Alastair |
collection | PubMed |
description | BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lines at rest. METHODS: Subjects 18 to 75 years old with at least mild glabellar lines at rest, as assessed by the validated Facial Wrinkle Scale (FWS) with photonumeric guide (score ≥ 1), received 3 treatments of 20 U onabotulinumtoxinA 4 months apart (N = 225). “Response” was defined as elimination of glabellar lines at rest (FWS score = 0) at any time point (Days 7, 30, 60, 90, and 120). Effect of treatment cycle on response was analyzed using repeated measures logistic regressions (p < .05). RESULTS: Most subjects were female (85%) and white (88%) (age range: 35–54 years). The likelihood of significant response was as follows: for all subjects combined (odds ratio [OR]: 1.31), for subjects with mild resting lines at baseline (OR: 1.49), and for older women (≥55 years) with mild resting lines at baseline (OR: 2.22). Of all subjects, 76% responded after 1 treatment, and 45% responded in all 3 cycles. CONCLUSION: Subjects repeatedly treated with onabotulinumtoxinA showed progressive improvement in glabellar lines at rest. |
format | Online Article Text |
id | pubmed-5414762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-54147622017-05-10 Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles Carruthers, Alastair Carruthers, Jean Fagien, Steven Lei, Xiaofang Kolodziejczyk, Julia Brin, Mitchell F. Dermatol Surg Original Article BACKGROUND: OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at rest; however, less is known regarding the effect of repeat treatment on more severe lines at rest. OBJECTIVE: To assess the effect of repeated onabotulinumtoxinA treatment for reduction of glabellar lines at rest. METHODS: Subjects 18 to 75 years old with at least mild glabellar lines at rest, as assessed by the validated Facial Wrinkle Scale (FWS) with photonumeric guide (score ≥ 1), received 3 treatments of 20 U onabotulinumtoxinA 4 months apart (N = 225). “Response” was defined as elimination of glabellar lines at rest (FWS score = 0) at any time point (Days 7, 30, 60, 90, and 120). Effect of treatment cycle on response was analyzed using repeated measures logistic regressions (p < .05). RESULTS: Most subjects were female (85%) and white (88%) (age range: 35–54 years). The likelihood of significant response was as follows: for all subjects combined (odds ratio [OR]: 1.31), for subjects with mild resting lines at baseline (OR: 1.49), and for older women (≥55 years) with mild resting lines at baseline (OR: 2.22). Of all subjects, 76% responded after 1 treatment, and 45% responded in all 3 cycles. CONCLUSION: Subjects repeatedly treated with onabotulinumtoxinA showed progressive improvement in glabellar lines at rest. Lippincott Williams & Wilkins 2016-09 2016-06-14 /pmc/articles/PMC5414762/ /pubmed/27427996 http://dx.doi.org/10.1097/DSS.0000000000000704 Text en © 2016 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Original Article Carruthers, Alastair Carruthers, Jean Fagien, Steven Lei, Xiaofang Kolodziejczyk, Julia Brin, Mitchell F. Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title | Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title_full | Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title_fullStr | Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title_full_unstemmed | Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title_short | Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles |
title_sort | repeated onabotulinumtoxina treatment of glabellar lines at rest over three treatment cycles |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414762/ https://www.ncbi.nlm.nih.gov/pubmed/27427996 http://dx.doi.org/10.1097/DSS.0000000000000704 |
work_keys_str_mv | AT carruthersalastair repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles AT carruthersjean repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles AT fagiensteven repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles AT leixiaofang repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles AT kolodziejczykjulia repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles AT brinmitchellf repeatedonabotulinumtoxinatreatmentofglabellarlinesatrestoverthreetreatmentcycles |